Tuesday, 8 September 2026Daily Edition · No. 001

The Other Headlines

There is more good in the world than the headlines suggest.

Bad news travels fast. Help good news travel faster.

Edition of Tuesday, 8 September 2026 · Five Stories of Progress · Return to today's edition

For Families Facing Advanced Pancreatic Cancer, an Approved New Drug Doubles Remaining Time Together

The FDA has approved daraxonrasib, an insurance-covered therapy shown to double survival time for patients with advanced pancreatic cancer whose tumors resisted chemotherapy. By giving patients viable treatment when standard options fail, the medicine offers families precious extra time against one of oncology's most unforgiving diseases. While not a cure, its immediate regulatory approval ensures swift access for those in urgent need.

Source: Good News Network

Read the original story →